Glaucoma - early detection and disease monitoring: an optometric challenge
18 November 2014
Volume 15, Issue 4
Cases of glaucoma continue to increase across the globe. Here, a number of experts discuss the importance of early detection in saving sight and halting this epidemic
Introduction
As a major cause of blindness and visual morbidity, glaucoma is an important public health issue. The number of people worldwide aged between 40 and 80 years who have glaucoma is predicted to increase from 64.3 million in 2013 to 111.8 million in 2040 (Tham et al. 2014). In 2010, it was estimated that, worldwide, the number of people bilaterally blind as a result of glaucoma was approximately 8.4 million and is likely to increase to 11.2 million by 2020 (Quigley and Broman 2006). Approximately half of these cases are due to angle closure glaucoma, which predominantly affects those of Asian ethnicity
Sign in to view the article
Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
Related further reading
New NICE guidance states that selective laser trabeculoplasty rather than eye drops should be a first-line treatment for glaucoma. Kim Thomas asks what this means for optometrists – and their patients.
The clinical figures that count.
Case study: Specialist optometrist Andrew J Morgan FCOptom discusses a case of ocular ischaemic syndrome and its differential diagnoses, central retinal vein occlusion and diabetic retinopathy.